EUVIMEDEUVIMED entdecken
Crossref

Y-90 post-radioembolization dosimetry comparison between SPECT and whole-body LAFOV PET/CT

K Zeimpekis, H Sari, N Gözlügöl, N R Achangwa, K Shi, M Schindewolf, A Afshar-Oromieh, A Rominger, R Seifert

Nuklearmedizin - NuclearMedicine · 01.03.2025 · 64 (01) · 68-69

DOI: 10.1055/s-0045-1804347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2025. Verfasst von K Zeimpekis und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziel/Aim: Long axial field-of-view (LAFOV) PET/CT scanners provide high sensitivity and extensive anatomical coverage, making them suitable for post-SIRT Y-90 imaging. These scans are essential to verify that the dose accurately targets tumors while sparing healthy organs. However, the feasibility of using LAFOV PET for this purpose and the dosimetry methods that yield precise measurements remain uncertain. Methodik/Methods: This retrospective analysis included 32 patients with HCC, CCC, or liver metastases. After SIRT, they underwent SPECT/CT and PET/CT (Biograph Quadra) with a 20-minute scan time. Tumor and lung (LMD) absorbed doses were measured using both an organ-based method (Simplicit90Y) and a voxel-based method (HERMIA Dosimetry). Additionally, the lung shunt fraction (LSF) was measured with HERMIA and compared with pre-treatment plans. Ergebnisse/Results: The median tumor doses for planning, post-treatment SPECT, and PET (SPECTpre, SPECTpost, PETpost) based on organ-wise dosimetry were 276.0 Gy (200.0–330.0 Gy), 232.0 Gy (158.5–303.5 Gy), and 267.5 Gy (182.5–370.8 Gy), respectively. In contrast, the median voxel-wise PETpost dose was significantly lower than the planned SPECTpre (152.5 Gy; 94.8–223.8 Gy; p

Zitieren

APA

Zeimpekis, K., Sari, H., Gözlügöl, N., Achangwa, N. R., Shi, K., Schindewolf, M., Afshar-Oromieh, A., Rominger, A., & Seifert, R. (2025). Y-90 post-radioembolization dosimetry comparison between SPECT and whole-body LAFOV PET/CT. Nuklearmedizin - NuclearMedicine, 64(01), 68-69. https://doi.org/10.1055/s-0045-1804347

Vancouver

Zeimpekis K, Sari H, Gözlügöl N, Achangwa NR, Shi K, Schindewolf M, et al. Y-90 post-radioembolization dosimetry comparison between SPECT and whole-body LAFOV PET/CT. Nuklearmedizin - NuclearMedicine. 2025;64(01):68-69. doi:10.1055/s-0045-1804347

BibTeX
@article{Zeimpekis2025,
  author = {Zeimpekis, K and Sari, H and Gözlügöl, N and Achangwa, N R and Shi, K and Schindewolf, M and Afshar-Oromieh, A and Rominger, A and Seifert, R},
  title = {Y-90 post-radioembolization dosimetry comparison between SPECT and whole-body LAFOV PET/CT},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2025},
  volume = {64},
  number = {01},
  pages = {68--69},
  doi = {10.1055/s-0045-1804347}
}
Kostenlos starten →